Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

dc.contributor.authorCitera, Gustavo
dc.contributor.authorBautista-Molano, Wilson Armando
dc.contributor.authorPeláez Ballestas, Ingris
dc.contributor.authorAzevedo, Valderilio F.
dc.contributor.authorPerich, Risto A.
dc.contributor.authorMéndez Rodríguez, José A.
dc.contributor.authorCutri, Mariel S.
dc.contributor.authorBorlenghi, Cecilia E.
dc.contributor.orcidBautista-Molano, Wilson Armando [0000-0003-0684-9542]
dc.contributor.orcidBautista-Molano, Wilson Armando [0000-0003-0684-9542]
dc.date.accessioned2021-03-08T15:55:20Z
dc.date.available2021-03-08T15:55:20Z
dc.date.issued2021
dc.description.abstractenglishLarge epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1186/S42358-020-00161-5
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn2523-3106
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/5565
dc.language.isoeng
dc.publisherBMCspa
dc.publisher.journalAdvances in Rheumatologyspa
dc.relation.ispartofseriesAdvances in Rheumatology, 2523-3106, Vol. 61, Nro. 1, 2021, p. 1-12spa
dc.relation.urihttps://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-020-00161-5
dc.rightsAttribution 4.0 International*
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2021
dc.rights.localAcceso abiertospa
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.keywordsPrevalencespa
dc.subject.keywordsSpondyloarthropathyspa
dc.subject.keywordsAnkylosing spondylitisspa
dc.subject.keywordsPsoriatic arthritisspa
dc.subject.keywordsLatin Americaspa
dc.titlePrevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritisspa
dc.title.translatedPrevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritisspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Citera_Gustavo_2020.pdf
Tamaño:
905.24 KB
Formato:
Adobe Portable Document Format
Descripción:
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones